Tear Fluid Biomarkers for Ocular Pain

Area of Science:

• Ophthalmology and Pain Research
• Biomarker Discovery
• Molecular Medicine

Background:

• Chronic ocular pain significantly impairs quality of life and is challenging to diagnose and treat.
• Its pathophysiological mechanisms are not fully understood, and clinical examinations may appear normal.
• Dry eye disease (DED) and post-surgical complications can trigger persistent, high-intensity ocular pain.

Purpose of the Study:

• To identify potential tear fluid biomarkers for objective diagnosis, monitoring, and treatment of ocular chronic pain.
• To explore molecular profiles in tears that correlate with chronic ocular pain conditions.
• To understand the molecular basis of ocular pain for developing targeted therapies.

Main Methods:

• Analysis of tear molecular profiles, including proteins, cytokines, and neuromediators.
• Quantification of specific molecules such as IL-9, MIP-1α, IL-10, IL-8, TNF-α, IL-6, Fractalkine, IL-1RA, Substance P, CGRP, NPY, and NGF.
• Investigation of preoperative tear levels of Calcitonin Gene-Related Peptide (CGRP) as a predictive factor.

Main Results:

• Specific molecular profiles in tear fluid are associated with the presence of chronic ocular pain.
• Elevated tear levels of certain cytokines and neuromediators are linked to ocular pain.
• Preoperative tear CGRP levels can predict the risk of developing ocular pain after refractive surgery.

Conclusions:

• Tear fluid biomarkers hold promise for diagnosing and managing ocular chronic pain.
• Understanding these molecular signatures can elucidate the differences in patient symptomatology and clinical parameters.
• Identifying individuals prone to ocular pain and developing personalized treatments are key future directions.